Effects of viral load on tenofovir vs. entecavir efficacy in recurrence prevention of hepatitis B virus-related hepatocellular carcinoma

被引：0
|
作者：
Qi Weili [1 ]
Shen Junyi [2 ]
Zhang Yu [3 ]
Gao Fengwei [4 ]
Li Chuan [1 ]
机构：
[1] Department of Liver Surgery and Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu, Sichuan, China
[2] Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China
[3] Organ Transplantation Center, Sichuan Provincial People’s Hospital, Chengdu, Sichuan, China
[4] HBPS Diseases Center for Diagnosis and Treatment of Leshan City, People’s Hospital of Leshan, Leshan, Sichuan,
来源：
中华医学杂志英文版 | 2023年 / 136卷 / 19期
关键词：
D O I：
暂无
中图分类号：
R512.62 []; R735.7 [肝肿瘤];
学科分类号：
摘要：
<正>
引用
收藏
相关论文
共 50 条
  • [21] SUPPRESSIVE EFFECTS OF ENTECAVIR ON VIRAL REPLICATION AND TUMOR PROLIFERATION IN PATIENTS WITH HEPATITIS B VIRUS-RELATED HEPATOCELLULAR CARCINOMA
    Kim, K. M.
    Lee, H. C.
    Yoo, D. J.
    Shim, J. H.
    Lim, Y. S.
    Chung, Y. H.
    Lee, Y. S.
    Suh, D. J.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S93 - S93
  • [22] Prevention of hepatitis B virus-related hepatocellular carcinoma
    Lin, Chih-Lin
    Kao, Jia-Horng
    HEPATOMA RESEARCH, 2021, 7
  • [23] Prevention of hepatitis B virus-related hepatocellular carcinoma
    Lok, ASF
    GASTROENTEROLOGY, 2004, 127 (05) : S303 - S309
  • [24] Tenofovir vs Entecavir on the Prognosis of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma After Liver Resection: The Role of HBsAg Levels
    Qiu, Zhancheng
    Xu, Yueqing
    Qi, Weili
    Shen, Junyi
    Wen, Tianfu
    Li, Chuan
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2025, 16 (03)
  • [25] Association of tenofovir and entecavir use with prognosis after surgical resection for hepatitis B virus-related hepatocellular carcinoma
    Yun, Byungyoon
    Ahn, Sang Hoon
    Oh, Juyeon
    Yoon, Jin-Ha
    Kim, Beom Kyung
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2022, 103 : 122 - 125
  • [26] Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma
    Liaw, YF
    SEMINARS IN LIVER DISEASE, 2005, 25 : 40 - 47
  • [27] Antiviral efficacy of lamivudine versus entecavir in patients with hepatitis B virus-related advanced hepatocellular carcinoma
    Shin, Hye Sun
    Kim, Seung Up
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Baatarkhuu, Oidov
    Ahn, Sang Hoon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2012, 27 (09) : 1528 - 1534
  • [28] Tenofovir versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma: a systematic review and meta-analysis
    Liu, Hui
    Han, Cheng-Long
    Tian, Bao-Wen
    Ding, Zi-Niu
    Yang, Ya-Fei
    Ma, Yun-Long
    Yang, Chun-Cheng
    Meng, Guang-Xiao
    Xue, Jun-Shuai
    Wang, Dong-Xu
    Dong, Zhao-Ru
    Chen, Zhi-Qiang
    Hong, Jian-Guo
    Li, Tao
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 17 (06) : 623 - 633
  • [29] The efficacies of entecavir and tenofovir in terms of enhancing prognosis after curative treatment of hepatitis B virus-related hepatocellular carcinoma
    Lee, Ji Hyun
    Kim, Beom Kyung
    Park, Soo Young
    Tak, Won Young
    Park, Jun Yong
    Kim, Do Young
    Ahn, Sang Hoon
    Sinn, Dong Hyun
    Kim, Seung Up
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 48 - 55
  • [30] Lamivudine vs. Entecavir for the newly diagnosed hepatitis B-virus related Hepatocellular carcinoma
    Kim, Jung Hee
    Sinn, Dong Hyun
    Kim, Kyunga
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    HEPATOLOGY, 2015, 62 : 422A - 423A
12345